WFNMB2022/JSNM2022/JSNMT2022

Presentation information

[JSNM]Radiopharmaceuticals2: Therapy1

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » [核医学]一般演題 口演

Radiopharmaceuticals2

Therapy1

Sat. Sep 10, 2022 9:50 AM - 10:50 AM Room6 (Kyoto International Conference Center 2F RoomB-2)

Chair:Tomoya Uehara (Graduate Shool of Pharmaceutical Sciences, Chiba University), Takeshi Fuchigami (Graduate School of Medical Sciences, Kanazawa Universiy)

[M2VIA3] Anti-tumor effect of intraperitoneal administration of astatine-labeled gold nanoparticles

Hiroki Kato1、Daisuke Katayama1、Kazuhiro Ooe1、Yuichiro Kadonaga2、Xuhao Huang3、Atsshi Shimoyama3、Kazuya Kabayama3、Koichi Fukase3、Jun Hatazawa1 (1.Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Japan、2.Division of Science, Institute for Radiation Sciences, Osaka University, Suita, Japan、3.Department of Chemistry, Graduate School of Science, Osaka University, Toyonaka, Japan)

Abstract password authentication.The password is described on page 8 of the "WFNMB2022 Program"

Password